文献速递细胞病理与分子病理

意义不明的异型性及ThyroSeq v3阳性率作为细胞学实验室性能质控指标

Atypia of undetermined significance and ThyroSeq v3-positive call rates as quality control metrics for cytology laboratory performance.
PubMed 文献 · Cancer Cytopathol · 2024-04-09

该研究回顾性分析4.5年内7535例甲状腺细胞学病例,按TBSRTC分层并收集分子检测结果,计算AUS率及分子阳性率(PCR)。结果显示实验室AUS率为17.5%,各细胞病理医师AUS率范围9.9%-36.8%,总体PCR为24%,纳入目前阴性结果后PCR升至35.5%。结论认为结合PCR的AUS率是评估实验室及医师性能的有用指标。

要点

  • AUS率结合分子阳性率可评估细胞学实验室及医师报告质量。
  • 实验室AUS率17.5%超过TBSRTC推荐的10%上限。
  • 各医师AUS率差异大(9.9%-36.8%),提示报告习惯不一致。

核心结论

  • AUS率结合PCR是评估细胞学实验室和细胞病理医师性能的有用指标。
  • 持续反馈该指标有助于提高甲状腺细胞学报告的整体质量。

研究设计与样本

  • 回顾性分析4.5年内所有甲状腺细胞学病例,共7535例。
  • 按TBSRTC分类,并收集不确定类别的分子检测结果。
  • 计算每位细胞病理医师及实验室的AUS率,以及加入目前阴性结果前后的分子阳性率(PCR)。

主要发现

  • 7535例中,不可诊断7.6%,良性69%,AUS 17.5%,滤泡性肿瘤/可疑滤泡性肿瘤1.4%,可疑恶性0.7%,恶性3.8%。
  • 每位细胞病理医师的AUS率范围为9.9%至36.8%。
  • 总体PCR为24%(每位医师范围13%-35.6%)。
  • 纳入目前阴性结果后,实验室PCR升至35.5%(每位医师范围13%-42.6%)。
  • 比较分析提示过度诊断良性病例与较少见的低诊断高级别TBSRTC病例并存。

关键数值与推荐

  • TBSRTC推荐AUS上限为10%。
  • 本实验室AUS率为17.5%,超过推荐上限。

临床怎么用

  • 可将AUS率与分子阳性率结合作为细胞学实验室质控指标。
  • 对细胞病理医师持续反馈AUS率及PCR,以改进甲状腺细胞学报告质量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) recommends an upper limit of 10% for atypia of undetermined significance (AUS). Recent data suggest that this category might be overused when the rate of cases with molecular positive results is low. As a quality metric, the AUS and positive call rates for this facility's cytology laboratory and each cytopathologist (CP) were calculated. METHODS: A retrospective analysis of all thyroid cytology cases in a 4.5-year period was performed. Cases were stratified by TBSRTC, and molecular testing results were collected for indeterminate categories. The AUS rate was calculated for each CP and the laboratory. The molecular positive call rate (PCR) was calculated with and without the addition of currently negative to the positive results obtained from the ThyroSeq report. RESULTS: A total of 7535 cases were classified as nondiagnostic, 7.6%; benign, 69%; AUS, 17.5%; follicular neoplasm/suspicious for follicular neoplasm, 1.4%; suspicious for malignancy, 0.7%; and malignant, 3.8%. The AUS rate for each CP ranged from 9.9% to 36.8%. The overall PCR was 24% (range, 13%-35.6% per CP). When including cases with currently negative results, the PCR increased to 35.5% for the cytology laboratory (range, 13%-42.6% per CP). Comparison analysis indicates a combination of overcalling benign cases and, less frequently, undercalling of higher TBSRTC category cases. CONCLUSIONS: The AUS rate in the context of PCR is a useful metric to assess cytology laboratory and cytopathologists' performance. Continuous feedback on this metric could help improve the overall quality of reporting thyroid cytology.

来源:Cancer Cytopathol,查看原文。版权归原作者所有。

引用

  1. Mejia-Mejia O, Bravo-Gonzalez A, Sanchez-Avila M, et al. Atypia of undetermined significance and ThyroSeq v3-positive call rates as quality control metrics for cytology laboratory performance. Cancer Cytopathol. 2024. PMID: 38594192. doi:10.1002/cncy.22821

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。